EUVIMEDEUVIMED entdecken
Crossref

Doubly Robust Estimators for Heterogeneous Treatment Effects in Heteroskedastic Survival Data

Yuhui Yang, Weiwei Hu, Zhenli Liao, Fangyao Chen

Statistics in Medicine · 2025

DOI: 10.1002/sim.70301 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Statistics in Medicine, 2025. Verfasst von Yuhui Yang und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Epidemiology and Biostatistics, School of Public Health, Xi'an Jiaotong University Health Science Center, Xi'an, Shaanxi, China. Hauptthemen laut MEDLINE: Treatment Effect Heterogeneity. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 45 Literaturangaben. Gefördert von: National Social Science Fund of China, National Office for Philosophy and Social Sciences.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Given the increasing interest focus on personalized medicine, a number of advanced statistical methods have been developed for estimating heterogeneous treatment effects (HTEs). However, methods for estimating HTEs in medical applications are limited, as they often involve potentially censored and heteroskedastic survival outcomes. Ignoring censoring and heteroskedasticity may introduce bias into HTEs. Therefore, in this study, we proposed two doubly robust (DR) methods for estimating HTEs based on nonparametric failure time (NFT) Bayesian additive regression trees (BART). Our contributions are as follows: (1) by using NFT BART as the prediction model, we avoid many restrictive assumptions, such as linearity, proportional hazards, and homoscedasticity; (2) we extend the DR‐Learner to survival data, allowing it to handle the common issue of censoring and confounding in observational data; (3) we conduct a comprehensive simulation study of the present HTEs estimation strategies using several data generation processes in which we systematically vary the sample size of the training set, treatment‐specific propensity score distribution, censoring rate, unbalanced treatment assignment, complexity of the model and bias function, and heteroskedastic or homoscedastic outcome. Through simulations, we demonstrate the effectiveness and robustness of the two proposed approaches in estimating HTEs. We also conduct a real data application of individualized hypertension management on observational data from the National Health and Nutrition Examination Survey (NHANES). Consequently, the proposed methods could yield robust estimates of HTE in observational survival data.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Treatment Effect HeterogeneityHumansBayes TheoremBiasComputer SimulationData Interpretation, StatisticalHypertensionModels, StatisticalPrecision MedicinePropensity ScoreSurvival AnalysisTreatment Outcome

Stichwörter der Autor:innen

conditional average treatment effectdoubly robustheterogeneous treatment effectsheteroskedastic datasurvival data

Autor:innen und Institutionen

  • Department of Epidemiology and Biostatistics, School of Public Health, Xi'an Jiaotong University Health Science Center, Xi'an, Shaanxi, China.
  • Department of Radiology, First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi, China.

Förderung

  • National Social Science Fund of China
  • National Office for Philosophy and Social Sciences

Zitieren

APA

Yang, Y., Hu, W., Liao, Z., & Chen, F. (2025). Doubly Robust Estimators for Heterogeneous Treatment Effects in Heteroskedastic Survival Data. Statistics in Medicine. https://doi.org/10.1002/sim.70301

Vancouver

Yang Y, Hu W, Liao Z, Chen F. Doubly Robust Estimators for Heterogeneous Treatment Effects in Heteroskedastic Survival Data. Statistics in Medicine. 2025. doi:10.1002/sim.70301

BibTeX
@article{Yang2025,
  author = {Yang, Yuhui and Hu, Weiwei and Liao, Zhenli and Chen, Fangyao},
  title = {Doubly Robust Estimators for Heterogeneous Treatment Effects in Heteroskedastic Survival Data},
  journal = {Statistics in Medicine},
  year = {2025},
  doi = {10.1002/sim.70301}
}
Kostenlos starten →